{
    "hands_on_practices": [
        {
            "introduction": "Understanding the functional impact of cholesteatoma is a cornerstone of otologic practice. This exercise demonstrates how to translate audiometric data into a quantitative measure of conductive hearing loss, the air–bone gap ($ABG$), which directly reflects the integrity of the ossicular chain. By calculating and interpreting the $ABG$ in a hypothetical case of chronic suppurative otitis media, you will practice linking diagnostic test results to underlying pathophysiology, a critical skill for assessing disease severity and counseling patients on the need for surgical intervention. ",
            "id": "5013893",
            "problem": "A patient with long-standing chronic suppurative otitis media and clinical features consistent with acquired cholesteatoma (attic retraction with keratin debris and malodorous otorrhea) undergoes pure-tone audiometry (PTA). Across the conventional speech frequencies $0.5$–$4$ kilohertz, the air conduction thresholds are uniformly $55$ decibel hearing level (dB HL), and the bone conduction thresholds are uniformly $20$ dB HL. Using only foundational definitions relating air conduction and bone conduction thresholds to conductive versus sensorineural hearing components, compute the mean air–bone gap (ABG) across $0.5$, $1$, $2$, and $4$ kilohertz, then use well-established clinical audiology principles to justify whether ossicular chain discontinuity is likely in this setting of chronic suppurative otitis media with suspected cholesteatoma. Report the mean ABG in dB HL. Round your numerical answer to two significant figures. Do not include units in the boxed final answer.",
            "solution": "The problem as stated is scientifically grounded, well-posed, and objective. It provides sufficient and consistent data from the field of clinical audiology to permit a formal, unique solution. The question is directly relevant to the pathophysiology of chronic suppurative otitis media with cholesteatoma, a topic within otorhinolaryngology.\n\nThe problem requires two distinct tasks: first, the computation of the mean air–bone gap (ABG), and second, a clinical interpretation of this finding in the context of the patient's diagnosis.\n\nFirst, we address the calculation of the mean air–bone gap. The air–bone gap at a specific frequency, denoted $ABG_f$, is defined as the difference between the air conduction (AC) threshold and the bone conduction (BC) threshold at that frequency. Both thresholds are measured in decibels hearing level (dB HL).\n\nThe formula is:\n$$ABG_f = AC_f - BC_f$$\nwhere $AC_f$ is the air conduction threshold at frequency $f$ and $BC_f$ is the bone conduction threshold at frequency $f$.\n\nThe problem provides the following givens:\n- A set of frequencies for analysis: $F = \\{0.5, 1, 2, 4\\}$ kilohertz.\n- A uniform air conduction threshold across these frequencies: $AC_f = 55$ dB HL for all $f \\in F$.\n- A uniform bone conduction threshold across these frequencies: $BC_f = 20$ dB HL for all $f \\in F$.\n\nGiven that the thresholds are uniform, the air–bone gap is constant across all tested frequencies.\nFor any frequency $f \\in F$, the ABG is:\n$$ABG_f = 55 - 20 = 35$$\nThe unit for this gap is decibels (dB).\n\nThe mean air–bone gap, denoted $\\overline{ABG}$, is the arithmetic mean of the individual ABG values at the specified frequencies:\n$$\\overline{ABG} = \\frac{\\sum_{f \\in F} ABG_f}{N}$$\nwhere $N$ is the number of frequencies, which is $4$.\n\nSubstituting the values:\n$$\\overline{ABG} = \\frac{ABG_{0.5 \\text{kHz}} + ABG_{1 \\text{kHz}} + ABG_{2 \\text{kHz}} + ABG_{4 \\text{kHz}}}{4}$$\n$$\\overline{ABG} = \\frac{35 + 35 + 35 + 35}{4} = \\frac{4 \\times 35}{4} = 35$$\nThe mean air–bone gap is $35$ dB HL. The problem requires the answer to be rounded to two significant figures. The number $35$ already has two significant figures ($3$ and $5$).\n\nSecond, we must provide a justification, based on well-established clinical audiology principles, for whether ossicular chain discontinuity is likely.\n\nThe air–bone gap is a measure of the conductive hearing loss component, which reflects the inefficiency of the sound-conducting mechanism of the outer and middle ear. The bone conduction thresholds ($20$ dB HL) represent the function of the sensorineural system (cochlea and auditory nerve), indicating a mild sensorineural hearing loss. The air conduction thresholds ($55$ dB HL) reflect the total hearing loss from all parts of the auditory system. The difference, the ABG of $35$ dB, is attributable solely to the conductive pathology.\n\nA key principle in audiology is that the magnitude of the ABG correlates with the severity of the conductive impairment. The maximum possible conductive hearing loss, which would manifest as a maximal ABG, is approximately $60$ dB. This theoretical maximum corresponds to a complete functional disconnection between the tympanic membrane and the cochlea, as would be seen in a total ossicular chain disruption with an intact, mobile tympanic membrane.\n\nIn this case, the mean ABG is $35$ dB. This is a moderate, clinically significant conductive hearing loss. The clinical context is chronic suppurative otitis media with suspected cholesteatoma. A cholesteatoma is an expansile, erosive lesion composed of keratinizing squamous epithelium. Its capacity to erode bone is a hallmark of the disease, and the auditory ossicles are particularly vulnerable.\n\nAn ABG of $35$ dB is strongly suggestive of significant ossicular chain pathology. While it is less than the maximal gap of $\\approx 60$ dB, it does not preclude ossicular discontinuity. There are two primary considerations:\n1.  The discontinuity may be partial. For instance, erosion of the long process of the incus, leading to separation of the incudostapedial joint, is the most common form of ossicular erosion from cholesteatoma. This partial disruption often results in an ABG in the range of $30$ to $50$ dB.\n2.  A complete ossicular disruption may be present, but the cholesteatoma matrix itself or associated granulation tissue could be bridging the gap. This phenomenon, sometimes called a \"columellar effect,\" can partially transmit sound vibrations from the tympanic membrane or malleus remnant to the stapes or oval window, thereby reducing the ABG to a value less than the theoretical maximum.\n\nTherefore, an ABG of $35$ dB in a patient with the clinical signs of cholesteatoma makes ossicular chain erosion and discontinuity highly likely. This audiometric finding is a classic presentation for this pathology and would be a strong indication for surgical exploration (tympanomastoidectomy) to remove the disease and reconstruct the ossicular chain.",
            "answer": "$$ \\boxed{35} $$"
        },
        {
            "introduction": "Effective management of Chronic Suppurative Otitis Media (CSOM) often relies on high-dose topical antibiotics to control infection. This practice problem delves into the core pharmacodynamic principles that justify this approach by asking you to calculate the ratio between the local drug concentration and the bacterium's Minimum Inhibitory Concentration ($MIC$). Mastering this concept allows you to appreciate the immense therapeutic advantage of topical delivery and provides a quantitative framework for evaluating treatment efficacy. ",
            "id": "5013919",
            "problem": "An adult patient with Chronic Suppurative Otitis Media (CSOM) caused by a Gram-negative bacillus has been prescribed topical ciprofloxacin ear drops with a labeled concentration of $2\\ \\mathrm{mg}/\\mathrm{mL}$. The bacterium’s Minimum Inhibitory Concentration (MIC) for ciprofloxacin, determined by standardized broth microdilution, is $0.5\\ \\mu\\mathrm{g}/\\mathrm{mL}$. The Minimum Inhibitory Concentration (MIC) is defined as the lowest antimicrobial concentration that prevents visible growth of a microorganism under standardized conditions. For concentration-dependent antimicrobials delivered topically in the ear canal, a dimensionless comparison between the achieved local drug concentration and the MIC of the target organism is used to assess whether the exposure plausibly exceeds the minimum threshold required for inhibition at the site of infection.\n\nAssume the following for the calculation: the effective free drug concentration at the point of contact in the ear canal is approximated by the labeled concentration, protein binding in the exudate is negligible, and dilution by middle ear effusion or cholesteatoma debris is ignored for the purpose of this first-principles estimate.\n\nCompute the ratio of the topical ciprofloxacin concentration to the MIC as a pure number. Express your answer as a dimensionless quantity with no units. No rounding is required; report the exact value. Then, based on fundamental pharmacodynamic principles of concentration-dependent killing and the definition of MIC, briefly interpret whether this ratio indicates that topical ciprofloxacin exposure is likely sufficient to inhibit planktonic organisms in CSOM, acknowledging potential limitations in the presence of biofilm or cholesteatoma matrix. Do not include any equations in your interpretation.",
            "solution": "The problem is subjected to validation before proceeding with a solution.\n\n**Step 1: Extract Givens**\n- Patient condition: Chronic Suppurative Otitis Media (CSOM) caused by a Gram-negative bacillus.\n- Medication: Topical ciprofloxacin ear drops.\n- Labeled concentration of ciprofloxacin: $2\\ \\mathrm{mg}/\\mathrm{mL}$.\n- Bacterium’s Minimum Inhibitory Concentration (MIC) for ciprofloxacin: $0.5\\ \\mu\\mathrm{g}/\\mathrm{mL}$.\n- Definition of MIC: The lowest antimicrobial concentration that prevents visible growth of a microorganism under standardized conditions.\n- Assumptions: Effective free drug concentration is the labeled concentration; protein binding is negligible; dilution by middle ear effusion or debris is ignored.\n- Task: Compute the ratio of the topical ciprofloxacin concentration to the MIC, and interpret this ratio.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is scientifically grounded, using standard pharmacological concepts (MIC, concentration-dependent killing) and clinically relevant values for a common otological scenario. The problem is well-posed, providing all necessary data ($2\\ \\mathrm{mg}/\\mathrm{mL}$ concentration, $0.5\\ \\mu\\mathrm{g}/\\mathrm{mL}$ MIC) and explicit assumptions to guide a unique calculation. The language is objective and precise. The problem does not violate any fundamental principles, is not incomplete or contradictory, and is not ill-posed.\n\n**Step 3: Verdict and Action**\nThe problem is deemed valid and a full solution will be provided.\n\nThe primary task is to compute the dimensionless ratio of the topical ciprofloxacin concentration to the Minimum Inhibitory Concentration (MIC) of the target bacterium.\n\nLet $C_{drug}$ be the concentration of ciprofloxacin in the ear drops and $MIC$ be the minimum inhibitory concentration for the bacterium. The givens are:\n$$C_{drug} = 2\\ \\mathrm{mg}/\\mathrm{mL}$$\n$$MIC = 0.5\\ \\mu\\mathrm{g}/\\mathrm{mL}$$\n\nTo compute a dimensionless ratio, the units of the numerator and the denominator must be identical. We will convert the units of $C_{drug}$ from milligrams per milliliter ($\\mathrm{mg}/\\mathrm{mL}$) to micrograms per milliliter ($\\mu\\mathrm{g}/\\mathrm{mL}$). The conversion factor between milligrams and micrograms is:\n$$1\\ \\mathrm{mg} = 1000\\ \\mu\\mathrm{g} = 10^3\\ \\mu\\mathrm{g}$$\n\nApplying this conversion to $C_{drug}$:\n$$C_{drug} = 2\\ \\frac{\\mathrm{mg}}{\\mathrm{mL}} \\times \\frac{10^3\\ \\mu\\mathrm{g}}{1\\ \\mathrm{mg}} = 2000\\ \\frac{\\mu\\mathrm{g}}{\\mathrm{mL}}$$\n\nNow that both concentrations are expressed in the same units, we can calculate the ratio $\\frac{C_{drug}}{MIC}$:\n$$\\text{Ratio} = \\frac{C_{drug}}{MIC} = \\frac{2000\\ \\mu\\mathrm{g}/\\mathrm{mL}}{0.5\\ \\mu\\mathrm{g}/\\mathrm{mL}}$$\n\nThe units ($\\mu\\mathrm{g}/\\mathrm{mL}$) cancel out, yielding a pure, dimensionless number. The numerical calculation is:\n$$\\text{Ratio} = \\frac{2000}{0.5} = \\frac{2000}{\\frac{1}{2}} = 2000 \\times 2 = 4000$$\n\nThe ratio of the topical ciprofloxacin concentration to the MIC is $4000$.\n\nFor the interpretation, we consider the pharmacodynamic principles of concentration-dependent antibiotics like ciprofloxacin and the definition of the MIC. A ratio of concentration to MIC significantly greater than one is generally required for therapeutic efficacy. In this case, the calculated ratio of four thousand indicates that the local drug concentration at the site of infection is several orders of magnitude higher than the minimum concentration required to inhibit the growth of the free-floating, or planktonic, bacteria. Based on these principles, this high ratio strongly suggests that the topical ciprofloxacin exposure is more than sufficient to inhibit the susceptible planktonic organisms responsible for the CSOM. However, it is critical to acknowledge the limitations of this estimate, as stated in the problem. The presence of a bacterial biofilm or a cholesteatoma matrix can significantly impede antibiotic penetration and effectiveness, meaning that even this high local concentration may not be sufficient to eradicate bacteria protected within these complex structures.",
            "answer": "$$\n\\boxed{4000}\n$$"
        },
        {
            "introduction": "The long-term surveillance of cholesteatoma presents one of the most challenging aspects of otology, often involving ambiguous clinical and radiological findings. This scenario forces a reconciliation between reassuring imaging results and persistent, suspicious physical signs, a common clinical dilemma after canal wall up surgery. By working through this case, you will apply principles of evidence-based medicine to formulate a follow-up plan that accounts for the known limitations of diagnostic tests and the non-zero probability of disease recurrence. ",
            "id": "5013904",
            "problem": "A $28$-year-old patient underwent canal wall up tympanoplasty with atticotomy for primary acquired cholesteatoma $9$ months ago. The postoperative course has been uncomplicated, and the ear is currently dry. Non-echo-planar diffusion-weighted magnetic resonance imaging (non-EPI DWI MRI) performed at $9$ months shows no focus of restricted diffusion suggestive of residual or recurrent cholesteatoma. However, otoscopy reveals a persistent, stable attic keratin crust within a shallow retraction pocket of the pars flaccida, without granulation or discharge.\n\nUsing first principles and core definitions, reconcile the imaging and otoscopic findings and select the most appropriate follow-up plan. Your reasoning should proceed from the following foundational facts:\n\n- A cholesteatoma is a keratinizing squamous epithelial lesion in the middle ear with a matrix that accumulates keratin debris and a perimatrix that can incite chronic inflammation and bone erosion.\n- Surgical eradication aims to remove all keratinizing epithelium; residual disease may be microscopic initially and grow incrementally over time.\n- Diffusion-weighted magnetic resonance imaging leverages the restricted diffusion of keratin to produce high signal intensity in cholesteatoma; non-EPI sequences reduce susceptibility artifacts and have high specificity. However, sensitivity is limited for lesions below approximately $2$–$3$ $\\mathrm{mm}$.\n- The likelihood of residual cholesteatoma after canal wall up surgery is non-zero; early postoperative imaging (approximately $6$–$12$ months) may have reduced sensitivity for very small lesions.\n- Bayes’ theorem links pretest probability and test characteristics to a post-test probability; a negative result with imperfect sensitivity does not reduce the probability of disease to zero.\n\nAssume the following plausible parameters for decision support (do not assume they are exact for any one institution, but use them to structure reasoning):\n\n- Pretest probability of residual cholesteatoma in this specific clinical context, given persistent but stable attic keratin crust, is approximately $p_0 = 0.40$.\n- At $9$ months, non-EPI DWI sensitivity for residual cholesteatoma lesions near or below the detection threshold is approximately $S = 0.70$, and specificity is approximately $C = 0.95$.\n- Residual cholesteatoma growth is slow, on the order of $1$ $\\mathrm{mm}$ per year, such that very small lesions may become detectable with additional time.\n\nWhich of the following follow-up plans best integrates these principles and the observed findings?\n\nA. Accept the negative non-EPI DWI MRI as conclusive; discharge the patient from specialty follow-up and avoid office debridement unless symptomatic.\n\nB. Maintain close otoscopic surveillance with periodic office debridement of the attic crust (for example, every $3$ months), reinforce water precautions, and schedule repeat non-EPI DWI MRI at around $18$ months postoperatively to increase detectability; reserve second-look surgery for progressive keratin accumulation, failure to visualize the pocket despite debridement, or a subsequent positive imaging result.\n\nC. Proceed to immediate second-look surgery despite the negative non-EPI DWI MRI, as any persistent keratin crust mandates re-exploration.\n\nD. Repeat non-EPI DWI MRI within $4$ weeks and, if negative, conclude there is no residual cholesteatoma; continue routine annual primary-care follow-up only.\n\nE. Replace MRI with high-resolution computed tomography (CT) immediately, because CT has superior sensitivity for residual cholesteatoma compared with diffusion-weighted sequences in the early postoperative period.",
            "solution": "The user's request is to validate and solve a clinical reasoning problem based on provided principles and parameters.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n\n*   **Patient Profile:** A $28$-year-old patient.\n*   **Surgical History:** Canal wall up tympanoplasty with atticotomy for primary acquired cholesteatoma, performed $9$ months ago.\n*   **Clinical Status:** Postoperative course is uncomplicated, ear is dry.\n*   **Otoscopic Findings:** A persistent, stable attic keratin crust within a shallow retraction pocket of the pars flaccida, without granulation or discharge.\n*   **Imaging Findings:** Non-echo-planar diffusion-weighted magnetic resonance imaging (non-EPI DWI MRI) at $9$ months shows no focus of restricted diffusion.\n*   **Foundational Facts:**\n    1.  A cholesteatoma is a keratinizing squamous epithelial lesion.\n    2.  Surgical goal is eradication, but microscopic residual disease can occur and grow.\n    3.  Non-EPI DWI MRI detects cholesteatoma via restricted diffusion of keratin. Its sensitivity is limited for lesions below approximately $2$–$3$ $\\mathrm{mm}$.\n    4.  Residual cholesteatoma risk after canal wall up surgery is non-zero.\n    5.  Bayes’ theorem is applicable; a negative test with imperfect sensitivity does not rule out disease.\n*   **Assumed Parameters:**\n    1.  Pretest probability of residual cholesteatoma ($D$): $P(D) = p_0 = 0.40$.\n    2.  Sensitivity of non-EPI DWI MRI at $9$ months: $S = P(\\text{Test Positive} | D) = 0.70$.\n    3.  Specificity of non-EPI DWI MRI at $9$ months: $C = P(\\text{Test Negative} | \\text{No Disease}) = 0.95$.\n    4.  Growth rate of residual cholesteatoma: approximately $1$ $\\mathrm{mm}$ per year.\n\n**Step 2: Validate Using Extracted Givens**\n\n*   **Scientifically Grounded:** The problem is firmly based on established principles of otology and neuroradiology. The description of cholesteatoma, the surgical approach (canal wall up tympanoplasty), the use of non-EPI DWI MRI for surveillance, and its known limitations (sensitivity for small lesions) are all factually correct and represent the standard of care and current understanding in the field.\n*   **Well-Posed:** The problem is well-posed. It presents a common clinical dilemma—conflicting clinical and imaging findings—and provides sufficient data and principles (including probabilistic parameters) to arrive at a logically derived, optimal management plan.\n*   **Objective:** The problem is stated in precise, objective clinical language. The inclusion of numerical values for pretest probability, sensitivity, and specificity allows for a quantitative, evidence-based approach, removing subjectivity.\n*   **Conclusion:** The problem statement is free of scientific flaws, contradictions, or ambiguities. It is a valid, well-structured problem in clinical reasoning.\n\n**Step 3: Verdict and Action**\n\nThe problem is valid. The solution process may proceed.\n\n### Solution Derivation\n\nThe central task is to reconcile the negative non-EPI DWI MRI finding with the persistent, suspicious otoscopic finding of an attic keratin crust. The problem directs the use of Bayes' theorem to quantify the post-test probability of residual cholesteatoma.\n\nLet $D$ be the event that the patient has residual cholesteatoma, and let $D^c$ be the event of no residual disease. Let $T^-$ be the event of a negative non-EPI DWI MRI result. We are asked to find the post-test probability, $P(D|T^-)$.\n\nThe given parameters are:\n*   Pretest probability (prior) of disease: $P(D) = 0.40$.\n*   Prior probability of no disease: $P(D^c) = 1 - P(D) = 1 - 0.40 = 0.60$.\n*   Sensitivity: $S = P(T^+ | D) = 0.70$. A $T^+$ indicates a positive test result.\n*   Specificity: $C = P(T^- | D^c) = 0.95$.\n\nFrom these, we can derive the probabilities of test outcomes conditional on disease state:\n*   The probability of a negative test given disease (false negative rate) is $P(T^-|D) = 1 - S = 1 - 0.70 = 0.30$.\n*   The probability of a negative test given no disease (true negative rate) is given directly as the specificity: $P(T^-|D^c) = C = 0.95$.\n\nAccording to the law of total probability, the overall probability of a negative test, $P(T^-)$, is:\n$$ P(T^-) = P(T^- | D)P(D) + P(T^- | D^c)P(D^c) $$\nSubstituting the values:\n$$ P(T^-) = (0.30)(0.40) + (0.95)(0.60) = 0.12 + 0.57 = 0.69 $$\n\nNow, we apply Bayes' theorem to calculate the posterior probability of disease given the negative test result:\n$$ P(D | T^-) = \\frac{P(T^- | D) P(D)}{P(T^-)} $$\nSubstituting the values:\n$$ P(D | T^-) = \\frac{(0.30)(0.40)}{0.69} = \\frac{0.12}{0.69} \\approx 0.1739 $$\n\nThus, despite the negative MRI, there remains an approximately $17.4\\%$ probability of residual cholesteatoma. This is a clinically significant risk and cannot be ignored. A management plan must account for this residual risk and the limitations of the diagnostic test. The limitation is that lesions smaller than $2$–$3$ $\\mathrm{mm}$ may not be detected. The provided growth rate of $\\sim 1$ $\\mathrm{mm}$ per year implies that waiting for a period (e.g., another $9$–$12$ months) will allow a potential microscopic lesion to grow to a size that is more likely to be detected by a subsequent scan.\n\n### Option-by-Option Analysis\n\n**A. Accept the negative non-EPI DWI MRI as conclusive; discharge the patient from specialty follow-up and avoid office debridement unless symptomatic.**\n\n*   **Reasoning:** This course of action is predicated on the assumption that the negative MRI reduces the probability of disease to near zero. Our calculation shows the post-test probability is $\\sim 17.4\\%$, which is a substantial risk. Discharging the patient from specialty follow-up would mean a potentially growing cholesteatoma is left unmonitored until it causes major complications. This option is reckless.\n*   **Verdict:** **Incorrect**.\n\n**B. Maintain close otoscopic surveillance with periodic office debridement of the attic crust (for example, every $3$ months), reinforce water precautions, and schedule repeat non-EPI DWI MRI at around $18$ months postoperatively to increase detectability; reserve second-look surgery for progressive keratin accumulation, failure to visualize the pocket despite debridement, or a subsequent positive imaging result.**\n\n*   **Reasoning:** This plan is a comprehensive and balanced approach that correctly integrates all the provided information.\n    1.  **Close surveillance and debridement:** This directly addresses the persistent clinical sign and allows for monitoring of the underlying pocket for any changes, which is essential given the calculated $17.4\\%$ risk.\n    2.  **Repeat MRI at $18$ months:** This acknowledges the sensitivity limitation of the initial scan and the slow growth of cholesteatoma. Waiting an additional $9$ months (from $9$ to $18$ months post-op) allows a potential small residual lesion to grow, increasing the sensitivity of the next scan.\n    3.  **Clear triggers for surgery:** It defines appropriate, objective criteria for escalating to surgical intervention, thus avoiding both premature surgery and negligent delay. This aligns perfectly with a strategy of \"watchful waiting\" informed by a quantitative risk assessment.\n*   **Verdict:** **Correct**.\n\n**C. Proceed to immediate second-look surgery despite the negative non-EPI DWI MRI, as any persistent keratin crust mandates re-exploration.**\n\n*   **Reasoning:** This approach is overly aggressive. While a keratin crust is suspicious, the negative MRI, even with its limitations, has successfully lowered the probability of disease from $40\\%$ to $17.4\\%$. This means there is an $82.6\\%$ chance that surgery would be negative ($P(D^c | T^-) = 1 - 0.174 = 0.826$). Subjecting a patient to the risks of revision ear surgery (anesthesia, facial nerve injury, hearing loss) is not justified when the probability of a negative finding is so high and a less invasive, robust surveillance strategy exists.\n*   **Verdict:** **Incorrect**.\n\n**D. Repeat non-EPI DWI MRI within $4$ weeks and, if negative, conclude there is no residual cholesteatoma; continue routine annual primary-care follow-up only.**\n\n*   **Reasoning:** This plan is flawed due to the proposed timeline. Given a cholesteatoma growth rate of approximately $1$ $\\mathrm{mm}$ per year, a $4$-week interval is far too short for a sub-threshold lesion to grow to a detectable size. The sensitivity of a scan performed at $10$ months post-op would be virtually identical to the one at $9$ months. Therefore, a second negative result would not significantly alter the risk profile, and discharging the patient based on it would be as inappropriate as it is in option A.\n*   **Verdict:** **Incorrect**.\n\n**E. Replace MRI with high-resolution computed tomography (CT) immediately, because CT has superior sensitivity for residual cholesteatoma compared with diffusion-weighted sequences in the early postoperative period.**\n\n*   **Reasoning:** This statement is factually incorrect. Non-EPI DWI MRI is the imaging modality of choice for detecting recurrent or residual cholesteatoma because of its ability to differentiate keratin (which has restricted diffusion) from other postoperative soft tissues like scar, granulation, and fluid. High-resolution CT excels at showing bone detail but has very poor soft-tissue resolution and cannot reliably distinguish cholesteatoma from these other tissues. The premise that CT has superior sensitivity in this context is false.\n*   **Verdict:** **Incorrect**.",
            "answer": "$$\\boxed{B}$$"
        }
    ]
}